Dallah Healthcare Company SJSC
SAU:4004

Watchlist Manager
Dallah Healthcare Company SJSC Logo
Dallah Healthcare Company SJSC
SAU:4004
Watchlist
Price: 162.2 SAR 0.12% Market Closed
Market Cap: 15.8B SAR
Have any thoughts about
Dallah Healthcare Company SJSC?
Write Note

Discount Rate

Cost of Equity
Discount Rate

12.56%
Cost of Equity
9.03%
Risk-Free Rate
0.87
Beta
4.06%
ERP

Dallah Healthcare Company SJSC's Cost of Equity, calculated using the formula Risk-Free Rate + Beta x ERP, stands at 12.56%. The Beta, indicating the stock's volatility relative to the market, is 0.87, while the current Risk-Free Rate, based on government bond yields, is 9.03%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.06%.

Loading Cost of Equity History...

WACC
Discount Rate

12.27%
WACC
11.3%
Debt Weight
10.03%
Cost of Debt
12.56%
Cost of Equity

Dallah Healthcare Company SJSC's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax. The WACC stands at 12.27%. This includes the cost of equity at 12.56%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 10.03%, reflecting the interest rate on Dallah Healthcare Company SJSC's debt adjusted for tax benefits. The weight of debt in the capital structure is 11.3%.

Loading WACC History...

What is Dallah Healthcare Company SJSC's discount rate?

Dallah Healthcare Company SJSC 's current Cost of Equity is 12.56%, while its WACC stands at 12.27%. The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.

For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.

For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate."

How is Cost of Equity for Dallah Healthcare Company SJSC calculated?

The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).

This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.

Here is how we calculate the cost of equity for Dallah Healthcare Company SJSC

Cost of Equity
12.56%
=
Risk-Free Rate
9.03%
+
Beta
0.87
x
ERP
4.06%

How is WACC for Dallah Healthcare Company SJSC calculated?

WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.

The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.

Here is how we calculate WACC for Dallah Healthcare Company SJSC

WACC
12.27%
=
Cost of Equity
12.56%
x
Equity Weight
89%
+
Cost of Debt
10.03%
x
Debt Weight
11%
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.